GW Pharmaceuticals Plc (GWPH)
GW Pharmaceuticals Plc (GWPH) Company Bio
GW Pharmaceuticals plc, a biopharmaceutical company, engages in discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. It operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. The company was founded in 1998 and is based in Cambridge, the United Kingdom.
GWPH Stock Chart More Charts
GWPH Price/Volume Stats
| Current price | $161.98 |
| Prev. close | $155.87 |
| Day low | $155.87 |
| Day high | $163.15 |
| 50-day MA | $163.09 |
| 200-day MA | $143.10 |
| 52-week high | $182.23 |
| 52-week low | $90.14 |
| Volume | 462,509 |
| Avg. volume | 477,676 |
| Dividend yield | N/A |
| Market Cap | 4.89B |
GWPH Returns
| 1-mo | -4.06% |
| 3-mo | 16.31% |
| 6-mo | 18.95% |
| 1-year | 22.31% |
| 3-year | 91.13% |
| 5-year | 133.67% |
| YTD | 66.32% |
| 2018 | -26.23% |
| 2017 | 18.13% |
| 2016 | 60.93% |
| 2015 | 2.60% |
| 2014 | 62.93% |
Loading social stream, please wait...